Carbetocin versus oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery: a randomised controlled trial.
OBJECTIVE
The objective of this study is to compare the effectiveness and safety of carbetocin vs. oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery.


METHODS
A prospective randomised study was conducted in which 100 pregnant women were randomised into 2 equal groups: group 1 received Carbetocin 100 µgm (Pabal(®) Ferring, UK) and group 2 received oxytocin 5 IU (Syntocinon(®), Novartis, Switzerland).


RESULTS
The amount of blood loss and the need for other uterotonics were significantly lower in the carbetocin group (811 ± 389.17 vs. 1010 ± 525.66 and 10/50 vs. 21/50). There was no significant difference between the carbetocin and oxytocin groups regarding occurrence of major PPH (6 vs. 11), the need for blood transfusion (6 vs. 9), the difference between blood haemoglobin levels before delivery and 24 h after delivery (0.6 ± 0.28 vs. 0.56 ± 0.25), respectively. There was no significant difference between the 2 study groups regarding both systolic and diastolic blood pressure measured immediately after the drug administration and at 30 and 60 min later. Regarding the drugs side effects, there was no significant difference between the 2 groups in the occurrence of nausea, vomiting, tachycardia, flushing, dizziness, headache, shivering, metallic taste, dyspnea, palpitations and itching.


CONCLUSIONS
Carbetocin is a better alternative to oxytocin in management of atonic PPH with non-significant hemodynamic changes or side effects .
Obstetrics and Gynaecology Department, Kasr Aini Hospital Cairo University, 1 Alsaraya street, Kasr AlAiny, Cairo, Egypt. prof.ahmedmaged@gmail.com.
Ahmed Mohamed
AM
Maged
Obstetrics and Gynaecology Department, Kasr Aini Hospital Cairo University, 1 Alsaraya street, Kasr AlAiny, Cairo, Egypt.
AbdelGany M A
AM
Hassan
Obstetrics and Gynaecology Department, Beni Suef University, Beni-Suef, Egypt.
Nesreen A A
NA
Shehata
D000328:Adult; D001794:Blood Pressure; D036861:Delivery, Obstetric / Q000379:methods*; D004244:Dizziness / Q000139:chemically induced; D004311:Double-Blind Method; D005260:Female; D006261:Headache / Q000209:etiology; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010120:Oxytocics / Q000009:adverse effects / Q000627:therapeutic use; D010121:Oxytocin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D011446:Prospective Studies; D013557:Switzerland; D016896:Treatment Outcome; D014717:Vertigo / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced
D010120:Oxytocics; D010121:Oxytocin; C020731:carbetocin
Atonic postpartum haemorrhage; Carbetocin; Oxytocin; Vaginal delivery